The fibrinogen-to-albumin ratio (FAR) which combines coagulation with nutritional status, is a new vital inflammatory biomarker for a variety of diseases, such as cervical cancer, oligodendroglial gliomas, acute coronary syndrome, and stroke (22–25). The gene discussed is ALB; the disease is Stroke.